Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd has received orders from the Commissioner of Income Tax (Appeals), Pune, concerning Assessment Years 2017-18 to 2023-24. While appeals for earlier years (2017-18 to 2020-21) were dismissed, appeals for 2021-22, 2022-23, and 2023-24 were partly allowed. The company disputes the aggregate demand of ₹62.69 crore reflected in these orders and plans to appeal further to the Income Tax Appellate Tribunal (ITAT). Krsnaa Diagnostics, based on expert advice, believes it has strong grounds for relief and expects substantial relief, stating these proceedings do not impact ongoing operations.

Krsnaa Diagnostics Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as per SEBI regulations. The report details the company's corporate identity, business activities primarily in diagnostic and healthcare services (accounting for 100% of turnover), and operational footprint across India. It also provides employee statistics, including 6,040 total employees (3,211 male, 2,830 female) and 1 differently-abled employee. The company operates on a standalone reporting basis and has not undertaken BRSR Core assurance. The report is available on the company's investor website.

Krsnaa Diagnostics Limited has announced its 16th Annual General Meeting (AGM) scheduled for September 28, 2026. The company also released its Annual Report for the Financial Year 2025-26, which includes the Business Responsibility and Sustainability Report. Members will have the option for remote e-voting from September 25-27, 2026, with September 21, 2026, set as the cut-off date for voting rights. The Register of Members and Share Transfer books will be closed from September 22-28, 2026.

Krsnaa Diagnostics Ltd has announced its 16th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 11:00 Hrs (IST) at its registered office in Pune. The company will present the Annual Report for the financial year 2025-26. Members will have the facility to exercise their votes electronically. The cut-off date for e-voting entitlement is September 21, 2026. Remote e-voting will be open from September 25 to September 27, 2026. The Register of Members and Share Transfer books will be closed from September 22 to September 28, 2026.

Krsnaa Diagnostics Ltd has received an order from the Assistant Commissioner of Income Tax, Pune, revising its tax demand for Assessment Year 2022-23. This rectification order, under Section 154 read with Section 143(3) of the Income Tax Act, applies the 60% rate under Section 115BBE to additions made in the original assessment. The revised balance payable is ₹31,73,28,734/-, an increase of ₹12,09,98,110/-. The company has already appealed the original assessment order and plans to appeal this additional demand.

Krsnaa Diagnostics Ltd announced a preferential issue of up to 16,21,000 warrants, convertible into equity shares, for a total amount of ₹91,74,86,000. The warrants will be issued to Mr. Rajendra Mutha and Krsnaa Diagnostics (Mumbai) Private Limited. The issue price is determined at ₹566 per warrant. Each warrant is convertible into one fully paid-up equity share of face value ₹5. The conversion can be exercised within 18 months from the allotment date. This move is expected to strengthen the company's capital base and potentially alter the shareholding structure.

Krsnaa Diagnostics Ltd has announced a Board of Directors meeting scheduled for August 13, 2026. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the board will evaluate a proposal for fundraising through the issuance of various securities, potentially including equity shares and warrants, via preferential issue or other permissible modes. The trading window for company securities will remain closed until August 15, 2026.

Krsnaa Diagnostics Ltd has signed a Public Private Partnership (PPP) Agreement with the Director Health Services, Government of Himachal Pradesh. This agreement expands the company's scope for setting up, operating, and managing CT Scan Diagnostic Facilities from 12 to 34 Government Health Institutions across the state. The project will be implemented on a PPP basis for an initial period of seven years, extendable by three years, and will largely operate on a cash basis. This significant expansion reinforces Krsnaa Diagnostics' position as a key service provider in the region and marks one of its largest government partnerships for CT scan services.

Krsnaa Diagnostics Ltd has announced the closure of its trading window from July 01, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. All directors, key managerial personnel, designated employees, promoters, and their immediate relatives are restricted from trading in the company's securities during this period to prevent potential insider trading. The date for the board meeting to approve these results will be communicated separately.

Krsnaa Diagnostics Ltd's board approved audited financial results for FY26 with an unmodified opinion from auditors. A final dividend of ₹2 per share (40% of face value) was recommended, subject to shareholder approval. The board also approved the appointment of M/s Kirtane & Pandit LLP as Statutory Auditors for FY27-31, and re-appointed internal, cost, and tax auditors for FY26-27.